Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B and AIP mutations: An update

Human Molecular Genetics

Volumn 16, Issue R1, 2007, Pages

  Karhu, Auli ^a   Aaltonen, Lauri A ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR INTERACTING PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; GROWTH HORMONE; HEAT SHOCK PROTEIN 90; HYPOPHYSIS HORMONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1 PROTEIN; ONCOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHODIESTERASE IV; PROLACTIN; PROTEIN KINASE A REGULATORY SUBUNIT 1 ALPHA; RETINOBLASTOMA PROTEIN; SURVIVIN; THYROID HORMONE RECEPTOR BETA; TRANSCRIPTION FACTOR JUND; TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 20; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

CANCER SCREENING; CARNEY COMPLEX; DIAGNOSTIC VALUE; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GROWTH HORMONE RELEASE; GROWTH HORMONE SECRETING ADENOMA; HORMONE RELEASE; HUMAN; HYPOPHYSIS ADENOMA; MULTIPLE ENDOCRINE NEOPLASIA; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROLACTIN RELEASE; PROLACTINOMA; PROTEIN FUNCTION; REVIEW; SOMATIC MUTATION;

ADENOMA; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MUTATION; PITUITARY NEOPLASMS; PROTEINS; PROTO-ONCOGENE PROTEINS;

EID: 34547774220     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddm036     Document Type: Review

References (52)

1. Heaney, A.P. and Melmed, S. (2004) Molecular targets in pituitary tumours. Nat. Rev. Cancer, 4, 285-295.
2. Arafah, B.M. and Nasrallah, M.P. (2001) Pituitary tumors: Pathology, clinical manifestation and management. Endocr. Relat. Cancer, 8 287-305.
3. Farrell, W.E. and Clayton, R.N. (2000) Molecular pathogenesis of pituitary tumors. Front. Neuroendocrinol., 21, 174-198.
4. Pellegata, N.S., Quintanilla-Martinez, L., Siggelkow, H., Samson, E., Bink, K., Höfler, H., Fend, F., Graw, J. and Atkinson, M.J. (2006) Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc. Natl. Acad. Sci. USA, 103 15558-15566.
5. Vierimaa, O., Georgitsi, M., Lehtonen, R., Vahteristo, P., Kokko, A., Raitila, A., Tuppurainen, K., Ebeling, T.M., Salmela, P.I., Paschke, R. et al. (2006) Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science, 312, 1228-1230.
6. Lucio-Camelo, D.C., Une, K.N., Ferreira, R.E.S., Khoo, S.K., Nickolov, R., Bronstein, M.D., Vaisman, M., Teh, B.T., Frohman, L.A., Mendonça, B.B. and Gadelha, M.R. (2004) A meiotic recombination in a new isolated familial somatotropinoma kindred. Eur. J. Endocrinol., 150, 643-648.
7. Daly, A.F., Jaffrain-Rea, M.L., Ciccarelli, A., Valdes-Socin, H., Rohmer, V., Tamburrano, G., Borson-Chazot, C., Estour, B., Ciccarelli, E., Brue, T. et al. (2006) Clinical characterization of familial isolated pituitary adenomas. J. Clin. Endocrinol. Metab., 91 3316-3323.
8. Marx, S.J., Agarwal, S.K., Kester, M.B., Heppner, C., Kim, Y.S., Skarulis, M.C., James, L.A., Goldsmith, P.K., Saggar, S.K., Park, S.Y. et al. (1999) Multiple endocrine neoplasia type 1: Clinical and genetic features of the hereditary endocrine neoplasias. Recent. Prog. Horm. Res., 54, 397-438.
9. Zhuang, Z., Ezzat, S.Z., Vortmeyer, A.O., Weil, R., Oldfield, E.H., Park, W.S., Paolo, S., Huang, S., Agarwal, S.K., Guru, S.C. et al. (1997) Mutations of the MEN1 tumor suppressor gene in pituitary tumors. Cancer Res., 57, 5446-5451.
10. Poncin, J., Stevenaert, A. and Beckers, A. (1999) Somatic MEN1 gene mutation does not contribute significantly to sporadic pituitary tumorigenesis. Eur. J. Endocrinol., 140, 573-576.
11. Burgess, J.R., Greenaway, T.M. and Shepherd, J.J. (1998) Expression of the MEN-1 gene in a large kindred with multiple endocrine neoplasia type 1. J. Intern. Med., 243, 465-470.
12. Thakker, R.V. (1998) Multiple endocrine neoplasia-syndromes of the twentieth century. J. Clin. Endocrinol. Metab., 83, 2617-2620.
13. Jagannathan, J., Dumont, A.S., Prevedello, D.M., Lopes, B., Oskouian, R.J., Jane, J.A., Jr. and Laws, E.R., Jr. (2005) Genetics of pituitary adenomas: Current theories and future implications. Neurosurg. Focus 19, E4.
14. Pannett, A.A.J. and Thakker, R.V. (1999) Multiple endocrine neoplasia type 1. Endocr. Relat. Cancer., 6, 449-473.
15. Turner, J.J., Leotlela, P.D., Pannett, A.A., Forbes, S.A., Bassett, J.H., Harding, B., Christie, P.T., Bowen-Jones, D., Ellard, S., Hattersley, A. et al. (2002) Frequent occurrence of an intron 4 mutation in multiple endocrine neoplasia type 1. J Clin Endocrinol. Metab., 87, 2688-2693.
16. Hai, N., Aoki, N., Shimatsu, A., Mori, T. and Kosugi, S. (2000) Clinical features of multiple endocrine neoplasia type 1 (MEN1) phenocopy without germline MEN1 gene mutations: Analysis of 29 Japanese sproradic cases with MEN1. Clin. Endocrinol. (Oxf), 52, 509-518.
17. Chandrasekharappa, S.C., Guru, S.C., Manickam, P., Olufemo, S.E., Collins, F.S., Emmert-Buck, M.R., Debelenko, L.V., Zhuang, Z., Lubensky, I.A., Liotta, L.A. et al. (1997) Positional cloning of the gene for multiple endocrine neoplasia-type I. Science, 276, 404-407.
18. Agarwal, S.K., Guru, S.C., Heppner, C., Erdos, M.R., Collins, R.M., Park, S.Y., Saggar, S., Chandrasekharappa, S.C., Collins, F.S., Spiegel, A.M. et al. (1999) Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell, 96, 143-152.
19. Yumita, W., Ikeo, Y., Yamauchi, K., Sakurai, A. and Hashizume, K. (2003) Suppression of insulin-induced AP-1 transactivation by menin accompanies inhibition of c-Fos induction. Int. J. Cancer, 103, 738-744.
20. Hepner, C., Bilimoria, K.Y., Agarwal, S.K., Kester, M., Whitty, L.J., Guru, S.C., Chandrasekharappa, S.C., Collins, F.S., Spiegel, A.M., Marx, S.J. et al. (2001) The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NFkappaB-mediated transactivation. Oncogene, 20, 4917-4925.
21. Kaji, H., Canaff, L., Lebrun, J.-J., Goltzman, D. and Hendy, G.N. (2001) Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling. Proc. Natl. Acad. Sci. USA, 98, 3837-3842.
22. Lemmens, I.H., Forsberg, L., Pannet, A.A., Meyen, E., Piehl, F., Turner, J.J., Van de Ven, W.J., Thakker, R.V., Larsson, C. and Kas, K. (2001) Menin interacts directly with the homeobox-containinig protein Pem. Biochem. Biophys. Res. Commun., 286, 426-431.
23. Ohkura, N., Kishi, M., Tsukada, T. and Yamaguchi, K. (2001) Menin, a gene product responsible for multiple endocrine neoplasia type 1, interacts with the putative tumor metastasis suppressor nm23. Biochem. Biophys. Res. Commun., 282, 1206-1210.
24. Yaguchi, H., Ohkura, N., Tsukada, T. and Yamaguchi, K. (2002) Menin, multiple endocrine neoplasia type 1 gene product, exhibits GTP-hydrolyzing activity in the presence of the tumor metastasis suppressor nm23. J. Biol. Chem., 277, 38197-38204.
25. Lopez-Egido, J., Cunningham, J., Berg, M., Oberg, K., Bongcam-Rudloff, E. and Gobl, A. (2002) Menin's interaction with glial fibrillary acidic protein and vimentin suggests a role for the intermediate filament network in regulating menin activity. Exp. Cell Res., 278, 175-183.
26. La, P., Canaff, A.C., Hou, Z., Wang, H., Schnepp, R.W., Yan, N., Shi, Y. and Hua, X. (2004) Direct binding of DNA tumor suppressor menin. J. Biol. Chem., 279, 49045-49054.
27. Fritz, A., Walch, A., Piotrowska, K., Rosemann, M., Schaffer, E., Weber, K., Timper, A., Wildner, G., Graw, J., Hofler, H. et al. (2002) Recessive transmission of a multiple endocrine neoplasia syndrome in the rat. Cancer Res., 62, 3048-3051.
28. Lidhar, K., Korbonits, M., Jordan, S., Khalimova, Z., Kaltsas, G., Lu, X., Clayton, R.N., Jenkins, P.J., Monson, J.P., Besser, G.M. et al. (1999) Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors. J. Clin. Endocrinol. Metab., 84, 3823-3830.
29. Milne, T.A., Hughes, C.M., Lloyd, R., Yang, Z., Rozenblatt-Rosen, O., Dou, Y., Schnepp, R.W., Krankel, C., Livolsi, V.A., Gibbs, D. et al. (2005) Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proc. Natl. Acad. Sci. USA., 102, 749-754.
30. Karnik, S.K., Hughes, C.M., Gu, X., Rozenblatt-Rosen, O., McLean, G.W., Xiong, Y., Meyerson, M. and Kim, S.K. (2005) Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. Proc. Natl. Acad. Sci. USA, 102 14659-14664.
31. Drosten, M., Hilken, G., Bockmann, M., Rodicker, F., Mise, N., Cranston, A.N., Dahmen, U., Ponder, B.A. and Putzer, B.M. (2004) Role of MEN2A-derived RET in maintenance and proliferation of medullary thyroid carcinoma. J. Natl. Cancer Inst., 96, 1231-1239.
32. Kolluri, S.K., Weiss, C., Koff, A. and Göttlicher, M. (1999) p27Kip1 induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. Genes Dev., 13, 1742-1753.
33. De Menis, E. and Prezant, T.R. (2002) Isolated familial somatotropinomas: Clinical features and analysis of the MEN1 gene. Pituitary, 5, 11-15.
34. Verloes, A., Stevenaert, A., Teh, B.T., Petrossians, P. and Beckers, A. (2000) Familial acromegaly: Case report and review of the literature. Pituitary, 1, 273-277.
35. Frohman, L.A. and Eguchi, K. (2004) Familial acromegaly. Growth Horm. IGF Res., 14, 90-96.
36. Soares, B.S., Eguchi, K. and Frohman, L.A. (2005) Tumor deletion mapping on chromosome 11q13 in 8 families with isolated familial somatotropinoma and in 15 sporadic somatotropinomas. J. Clin. Endocrinol. Metabol. 90, 6580-6587.
37. Georgitsi, M., Raitila, A., Karhu, A., Tuppurainen, K., Mäkinen, M.J., Vierimaa, O., Paschke, R., Saeger, W., van der Luijt, R.B., Sane, T. et al. (2007) Molecular diagnosis of pituitary adenoma predisposition, caused by aryl hydrocarbon receptor interacting protein gene mutations. Proc. Natl. Acad. Sci. USA, 104, 4101-4105.
38. Daly, A.F., Vanbellinghen, J-F., Khoo, S.K., Jaffrain-Rea, M-L., Naves, L.A., Guitelma, M.A., Murat, A., Emy, P., Gimenez-Roqueplo, A-P., Tamburrano, G. et al. (2007) Aryl hydrocarbon interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J. Clin. Endocrin. Metab., doi:10.1210/ jc.2006-2513.
39. Barlier, A., Vanbellinghen, J-F., Daly, A.F., Silvy, M., Jaffrain-Rea, M-L., Trouillas, J., Tamagno, G., Cazabat, L., Bours, V., Enjalbert, A. et al. (2007) Mutations in aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas. J. Clin. Endocrin. Metab., doi:10.1210/ jc.2006-2702.
40. Georgitsi, M., Karhu, A., Winqvist, R., Visakorpi, T., Waltering, K., Vahteristo, P., Launonen, V. and Aaltonen, L.A. (2006) Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) in colorectal, breast, and prostate cancers. Br. J. Cancer, 96, 352-356.
41. Carver, L.A. and Bradfield, C.A. (1997) Ligand-dependent interaction of the aryl hydrocarbon receptor with a novel immunophilin homolog in vivo. J. Biol. Chem., 272, 11452-11456.
42. Meyer, B.K. and Perdew, G.H. (1999) Characterization of the AhR-hsp90-XAP2 core complex and the role of the immunophilinrelated protein XAP2 in AhR stabilization. Biochemistry, 38, 8907-8917.
43. Marlowe, J.L. and Puga, A. (2005) Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis. J. Cell Biochem., 96 1174-1184.
44. Pollenz, R.S. and Dougherty, E.J. (2005) Redefining the role of the endogenous XAP2 and C-terminal hsp70-interacting protein on the endogenous Ah receptors expressed in mouse and rat cell lines. J. Biol. Chem., 280, 33346-33356.
45. Bell, D.R. and Poland, A. (2000) Binding of aryl hydrocarbon receptor (AhR) to AhR-interacting protein. The role of hsp90. J. Biol. Chem. 275, 36407-36414.
46. Petrulis, J.R. and Perdew, G.H. (2002) The role of chaperone proteins in the aryl hydrocarbon receptor core complex. Chem. Biol. Interact., 141, 25-40.
47. Bolger, G.B., Peden, A.H., Steele, M.R., MacKenzie, C., McEwan, D.G., Wallace, D.A., Huston, E., Baillie, G.S. and Houslay, M.D. (2003) Attenuation of the activity of the cAMP-specific phosphodiesterase PDE4A5 by interaction with the immunophilin XAP2. J. Biol. Chem., 278, 3351-3363.
48. Sumanasekera, W.K., Tien, E.S., Turpey, R., Vanden Heuvel, J.P. and Perdew, G.H. (2003) Evidence that peroxisome proliferator-activated receptor alpha is complexed with the 90-kDa heat shock protein and the hepatitis virus B X-associated protein 2. J. Biol. Chem., 278 4467-4473.
49. Kang, B.H. and Altieri, D.C. (2006) Regulation of survivin stability by the aryl hydrocarbon receptor-interacting protein. J. Biol. Chem., 281, 24721-24727.
50. Yano, M., Terada, K. and Mori, M. (2003) AIP is a mitochondrial import mediator that binds to both import receptor Tom20 and preproteins. J. Cell Biol., 163, 45-56.
51. Clerget Froidevaux, M-S.C., Berg, P., Seugnet, I., Decherf, S., Becker, N., Sachs, L.M., Bilesimo, P., Nygård, M., Pongratz, I. and Demeneix, B.A. (2006) The co-chaperone XAP2 is required for activation of hypothalamic thyrotropin-releasing hormone transcription in vivo. EMBO Rep., 7, 1035-1039.
52. Larimore, T.C., Piersall, M.K., DeBenedetti, M.K., Dilley, W.G., Mutch, M.G., Whelan, A.J. and Zehnbauer, B. (2004) Clinical genetic testing and early surgical intervention in patients with multiple endocrine neoplasia type 1 (MEN1). Ann. Surg., 239, 645-647.